After over 30 years of serving as a cornerstone in Jamaica’s diagnostic imaging landscape, Apex Radiology is entering a pivotal new phase marked by executive realignment, operational resilience, and targeted expansion.
Leadership Realignment Anchored in Experience
The company will usher in a new era of leadership with Dr Steven Lewis ascending to the role of chairman on March 1, 2026. A seasoned consultant radiologist and board member for over two decades, Lewis’ appointment ensures strategic continuity while positioning the organization for forward thrust. He succeeds Dr Karlene McDonnough, the founder who will transition out of the chairmanship after decades of leadership but remain active as executive director and lead consultant for nuclear medicine.
This recalibration at the top comes not as a disruption but as a carefully staged evolution. McDonnough’s presence on the board preserves institutional memory, while Lewis’ operational and governance history allows for seamless leadership transition.
Weathering Storms, Delivering Growth
Despite challenges including Hurricane Melissa’s impact on patient volumes and clinic operations — especially outside the Kingston area — Apex posted its best quarterly performance of the 2026 financial year in the third quarter, with revenues climbing to $277.2 million.
Cumulative nine-month revenue reached $803.3 million, a slight year-on-year dip attributed to the hurricane’s disruptions and lower scan volumes. Nonetheless, Apex maintained healthy margins through cost containment, with administrative expenses kept in check and gross profitability intact. Profit before tax landed at $33.1 million for the period.
Strategic Acquisitions Bolster Platform Depth
Apex continued to execute on its expansion blueprint, acquiring the diagnostic imaging arm of The Woman’s Place for approximately $69.8 million. This move marks Apex’s official foray into a mammography-centered platform and adds a specialized edge to its service offering.
Early indicators validate the acquisition: within the first full month, the newly onboarded unit accounted for over 8% of total scan volume — a material contribution that reinforces the strategic merit of the deal. The acquisition also saw Apex recognize $49.4 million in intangible assets, reflecting the embedded brand and customer goodwill.
Expansion Pipeline and New Buildout
The company has signaled that further acquisitions are on the radar, with a second deal expected to be disclosed before the close of the 2026 financial year. In parallel, construction continues on its upcoming flagship location at 33 LMR, aimed at significantly increasing patient throughput and service capacity upon completion.
Conclusion
Apex Radiology is moving decisively — executing a leadership handover rooted in institutional depth while balancing short-term headwinds and long-term ambitions. As it eyes further inorganic growth and operational scale, the company is signaling that it’s not just adapting to change — it’s engineering its own evolution.
